Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
GIP receptor activation adds: Enhanced fat metabolism: GIP receptors on adipose tissue promote fat breakdown and reduce fat storage, adding a metabolic dimension to weight loss beyond appetite suppression alone Additive appetite suppression: GIP and GLP-1 receptor activation together produce greater appetite reduction than either pathway alone Improved insulin sensitivity: The combination improves peripheral insulin sensitivity more effectively than GLP-1 activation alone particularly relevant for patients with insulin resistance or type 2 diabetes Tirzepatide is sold under the brand names Mounjaro (diabetes indication) and Zepbound (obesity indication) and is also available as a compounded medication
For people on long-term hormonal therapy, weve anecdotally seen that use of concurrent weight loss medications appears to be feasible
Read More: #BFBiosciences #PharmaIndustry #HealthcareInnovation #Zeptide #Tirzepatide #DiabetesCare #ObesityTreatment #PakistanPharma #MedicalInnovation #HealthTech BF Biosciences launches Tirzepatide in Pakistan BF Biosciences [A Subsidiary Of Ferozsons Laboratories Limited] (PSX: BFBIO) has successfully launched Zeptide (Tirzepatide) an innovative medication targeting diabetes and obesity, now introduced in a user-friendly pre-filled syringe format
At full retail with no discount, it is $12,000 to $16,000 per year
Mistake #7: Not Tracking What Works and What Doesn't Why it's wrong: By day 7, you won't remember what made you feel good versus what made you feel terrible
Telehealth Appointment: Complete your evaluation and receive your prescription through our app
